keyword
https://read.qxmd.com/read/38689181/the-modulation-of-autophagy-and-unfolded-protein-response-by-ent-kaurenoid-derivative-cpuk02-in-human-colorectal-cancer-cells
#21
JOURNAL ARTICLE
Sedigheh Rezayi, Morvarid Siri, Nasim Rahmani-Kukia, Mozhdeh Zamani, Sanaz Dastghaib, Pooneh Mokarram
BACKGROUND: CPUK02 (15-Oxosteviol benzyl ester) is a semi-synthetic derivative of stevioside known for its anticancer effects. It has been reported that the natural compound of stevioside and its associated derivatives enhances the sensitivity of cancer cells to conventional anti-cancer agents by inducing endoplasmic reticulum (ER) stress. In response to ER stress, autophagy and unfolded protein responses (UPR) are activated to restore cellular homeostasis. Consequently, the primary aim of this study is to investigate the impact of CPUK02 treatment on UPR and autophagy markers in two colorectal cancer cell lines...
April 30, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38688635/ghrelin-induces-the-production-of-hypothalamic-npy-through-the-ampk-mtor-pathway-to-alleviate-cancer-induced-bone-pain
#22
JOURNAL ARTICLE
Longjie Xu, Lili Hou, Chun Cao, Xiaohua Li
BACKGROUND/AIM: Cancer-induced bone pain (CIBP) is one of the most common symptoms of bone metastasis of tumor cells. The hypothalamus may play a pivotal role in the regulation of CIBP. However, little is known about the exact mechanisms. MATERIALS AND METHODS: First, we established a CIBP model to explore the relationship among hypothalamic ghrelin, NPY and CIBP. Then, we exogenously administered NPY and NPY receptor antagonists to investigate whether hypothalamic NPY exerted an antinociceptive effect through binding to NPY receptors...
2024: In Vivo
https://read.qxmd.com/read/38685367/early-administration-of-wumei-wan-inhibit-myeloid-derived-suppressor-cells-via-pi3k-akt-pathway-and-amino-acids-metabolism-to-prevent-colitis-associated-colorectal-cancer
#23
JOURNAL ARTICLE
Zhi-Hua Lu, Yang Ding, Yu-Ji Wang, Chen Chen, Xing-Ran Yao, Xiao-Min Yuan, Fan Bu, Han Bao, Yu-Wei Dong, Qiao Zhou, Lu Li, Tuo Chen, Yang Li, Jin-Yong Zhou, Qiong Wang, Guo-Ping Shi, Feng Jiang, Yu-Gen Chen
ETHNOPHARMACOLOGICAL RELEVANCE: Wumei Wan (WMW), a traditional Chinese medicine prescription, has been proved to be effective in treating Colitis-associated colorectal cancer (CAC), but it has not been proven to be effective in different stages of CAC. AIM OF THE STUDY: The purpose of our study is to investigate the therapeutic effect and mechanism of WMW on the progression of CAC. MATERIALS AND METHODS: Azioximethane (AOM) and dextran sulfate sodium (DSS) were used to treat mice for the purpose of establishing CAC models...
April 27, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38683979/%C3%AE-catenin-turnover-is-regulated-by-nek10-mediated-tyrosine-phosphorylation-in-a549-lung-adenocarcinoma-cells
#24
JOURNAL ARTICLE
Previn Dutt, Nasir Haider, Samar Mouaaz, Lauren Podmore, Vuk Stambolic
β-catenin has influential roles affecting embryonic development, tissue homeostasis, and human diseases including cancer. Cellular β-catenin levels are exquisitely controlled by a variety of regulatory mechanisms. In the course of exploring the functions of the Nek10 tyrosine kinase, we observed that deletion of Nek10 in lung adenocarcinoma cells resulted in dramatic stabilization of β-catenin, suggestive of a Nek10 role in the control of β-catenin turnover. Nek10-deficient cells exhibited diminished ability to form tumorspheres in suspension, grow in soft agar, and colonize mouse lung tissue following tail vein injection...
May 7, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38681991/osw-1-triggers-necroptosis-in-colorectal-cancer-cells-through-the-ripk1-ripk3-mlkl-signaling-pathway-facilitated-by-the-ripk1-p62-sqstm1-complex
#25
JOURNAL ARTICLE
Nan Wang, Chao-Yang Li, Teng-Fei Yao, Xiao-Dan Kang, Hui-Shu Guo
BACKGROUND: Necroptosis has emerged as a novel molecular pathway that can be targeted by chemotherapy agents in the treatment of cancer. OSW-1, which is derived from the bulbs of Ornithogalum saundersiae Baker, exerts a wide range of pharmacological effects. AIM: To explore whether OSW-1 can induce necroptosis in colorectal cancer (CRC) cells, thereby expanding its range of clinical applications. METHODS: We performed a sequence of functional experiments, including Cell Counting Kit-8 assays and flow cytometry analysis, to assess the inhibitory effect of OSW-1 on CRC cells...
April 21, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38677768/dna-checkpoint-gene-mutation-as-a-biomarker-for-immune-checkpoint-inhibitor-therapy-in-advanced-biliary-tract-cancer
#26
JOURNAL ARTICLE
Ji Eun Shin, Seung Tae Kim
BACKGROUND/AIM: The DNA checkpoint (DNACHK) pathway is engaged in signaling the need for cell cycle arrest. This pathway is being actively researched to assess its role in cancer immunotherapy. PATIENTS AND METHODS: A total of 62 patients participated in this study. These patients were treated with immune checkpoint inhibitors (ICIs) for advanced biliary tract cancers (BTCs) from March 2020 to August 2022 at Samsung Medical Center. DNACHK mutated were defined as genomic alterations, such as single nucleotide variants, multi-nucleotide variants, and short insertion and deletions in seven genes; checkpoint kinase 1 (CHEK1), checkpoint kinase 2 (CHEK2), BRCA1, DNA repair-associated (BRCA1), the serine/threonine kinase ATM, the serine/threonine kinase ATR, mediator of DNA damage checkpoint 1 (MDC1) and tumor protein p53 binding protein 1 (TP53BP1)...
May 2024: Anticancer Research
https://read.qxmd.com/read/38675428/structural-investigations-on-2-amidobenzimidazole-derivatives-as-new-inhibitors-of-protein-kinase-ck1-delta
#27
JOURNAL ARTICLE
Sara Calenda, Daniela Catarzi, Flavia Varano, Erica Vigiani, Rosaria Volpini, Catia Lambertucci, Andrea Spinaci, Letizia Trevisan, Ilenia Grieco, Stephanie Federico, Giampiero Spalluto, Gianluca Novello, Veronica Salmaso, Stefano Moro, Vittoria Colotta
Protein kinase CK1δ (CK1δ) is a serine-threonine/kinase that modulates different physiological processes, including the cell cycle, DNA repair, and apoptosis. CK1δ overexpression, and the consequent hyperphosphorylation of specific proteins, can lead to sleep disorders, cancer, and neurodegenerative diseases. CK1δ inhibitors showed anticancer properties as well as neuroprotective effects in cellular and animal models of Parkinson's and Alzheimer's diseases and amyotrophic lateral sclerosis...
April 7, 2024: Pharmaceuticals
https://read.qxmd.com/read/38672622/bub1-promotes-gemcitabine-resistance-in-pancreatic-cancer-cells-by-inhibiting-ferroptosis
#28
JOURNAL ARTICLE
Weiming Wang, Xiang Zhou, Lingming Kong, Zhenyan Pan, Gang Chen
The development of chemotherapy resistance severely limits the therapeutic efficacy of gemcitabine (GEM) in pancreatic cancer (PC), and the dysregulation of ferroptosis is a crucial factor in the development of chemotherapy resistance. BUB1 Mitotic Checkpoint Serine/Threonine Kinase (BUB1) is highly overexpressed in PC patients and is closely associated with patient prognosis. However, none of the literature reports the connection between BUB1 and ferroptosis. The molecular mechanisms underlying GEM resistance are also not well understood...
April 18, 2024: Cancers
https://read.qxmd.com/read/38671459/sf3b3-regulated-mtor-alternative-splicing-promotes-colorectal-cancer-progression-and-metastasis
#29
JOURNAL ARTICLE
Tong Xu, Xichuan Li, Wennan Zhao, Xue Wang, Leixin Jin, Zhiqiang Feng, Huixiang Li, Mingzhe Zhang, Yiqing Tian, Ge Hu, Yuan Yue, Xintong Dai, Changliang Shan, Weihua Zhang, Chunze Zhang, Youcai Zhang
BACKGROUND: Aberrant alternative splicing (AS) is a pervasive event during colorectal cancer (CRC) development. SF3B3 is a splicing factor component of U2 small nuclear ribonucleoproteins which are crucial for early stages of spliceosome assembly. The role of SF3B3 in CRC remains unknown. METHODS: SF3B3 expression in human CRCs was analyzed using publicly available CRC datasets, immunohistochemistry, qRT-PCR, and western blot. RNA-seq, RNA immunoprecipitation, and lipidomics were performed in SF3B3 knockdown or overexpressing CRC cell lines...
April 26, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38670586/germline-myof1-wnk4-and-vps25-myof1-chimeras-generated-by-the-constitutional-translocation-t-17-19-q21-p13-in-two-siblings-with-myelodysplastic-syndrome
#30
JOURNAL ARTICLE
Ioannis Panagopoulos, Kristin Andersen, Vidar Stavseth, Synne Torkildsen, Sverre Heim, Maren Randi Tandsæther
BACKGROUND/AIM: Constitutional chromosomal aberrations are rare in hematologic malignancies and their pathogenetic role is mostly poorly understood. We present a comprehensive molecular characterization of a novel constitutional chromosomal translocation found in two siblings - sisters - diagnosed with myelodysplastic syndrome (MDS). MATERIALS AND METHODS: Bone marrow and blood cells from the two patients were examined using G-banding, RNA sequencing, PCR, and Sanger sequencing...
2024: Cancer Genomics & Proteomics
https://read.qxmd.com/read/38670305/ankzf1-knockdown-inhibits-glioblastoma-progression-by-promoting-intramitochondrial-protein-aggregation-through-mitorqc
#31
JOURNAL ARTICLE
Guangzhao Li, Zongqi Wang, Bixi Gao, Kun Dai, Xiaowang Niu, Xiang Li, Yunjiang Wang, Longyuan Li, Xin Wu, Haiying Li, Zhengquan Yu, Zhong Wang, Gang Chen
Protein homeostasis is fundamental to the development of tumors. Ribosome-associated quality-control (RQC) is able to add alanine and threonine to the stagnant polypeptide chain C-terminal (CAT-tail) when protein translation is hindered, while Ankyrin repeat and zinc-finger domain-containing-protein 1 (ANKZF1) can counteract the formation of the CAT-tail, preventing the aggregation of polypeptide chains. In particular, ANKZF1 plays an important role in maintaining mitochondrial protein homeostasis by mitochondrial RQC (mitoRQC) after translation stagnation of precursor proteins targeting mitochondria...
April 24, 2024: Cancer Letters
https://read.qxmd.com/read/38668684/ginsenoside-rg1-induces-autophagy-in-colorectal-cancer-through-inhibition-of-the-akt-mtor-p70s6k-pathway
#32
JOURNAL ARTICLE
Ruiqi Liu, Bin Zhang, Shuting Zou, Li Cui, Lin Lin, Lingchang Li
This study aimed to elucidate the anti-colon cancer mechanism of ginsenoside Rg1 in vitro and in vivo. Cell viability rate was detected using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) tetrazolium assay. The inhibitory effect of ginsenoside Rg1 against CT26 cell proliferation gradually increased with increasing concentration. The in vivo experiments also demonstrated an antitumor effect. The monodansylcadaverine (MDC), transmission electron microscopy (TEM), and expression of autophagy marker proteins confirmed that ginsenoside Rg1 induced autophagy in vitro...
April 28, 2024: Journal of Microbiology and Biotechnology
https://read.qxmd.com/read/38664366/a-potential-strategy-for-bladder-cancer-treatment-inhibiting-autophagy-to-enhance-antitumor-effects-of-nectin-4-mmae
#33
JOURNAL ARTICLE
Yichen Wang, Yanyang Nan, Chunguang Ma, Xiaolin Lu, Qian Wang, Xiting Huang, Wenjing Xue, Jiajun Fan, Dianwen Ju, Dingwei Ye, Xuyao Zhang
Research and development on Nectin-4 antibody-drug conjugates (ADC) have been greatly accelerated since the approval of enfortumab vedotin to treat uroepithelial cancer. During the course of this study, we identified that autophagy serves as a cytoprotective mechanism during Nectin-4-MMAE treatment and proposed a strategy to enhance the antitumor effects of Nectin-4-MMAE in bladder cancer. Nectin-4-MMAE rapidly internalized into bladder cancer cells in 30 minutes and released MMAE, inducing the onset of caspase-mediated apoptosis and leading to the inhibition of tumor cell growth...
April 25, 2024: Cell Death & Disease
https://read.qxmd.com/read/38661550/defining-the-in-vivo-role-of-mtorc1-in-thyrocytes-by-studying-the-tsc2-conditional-knockout-mouse-model
#34
JOURNAL ARTICLE
Camila Ludke Rossetti, Bruna Lourenconi Alves, Flavia Leticia Martins Pecanha, Aime Franco, Vania Nosé, Everardo Magalhães Carneiro, John I Lew, Ernesto Bernal-Mizrachi, Joao Pedro Werneck de Castro
BACKGROUND: The thyroid gland is susceptible to abnormal epithelial cell growth, often resulting in thyroid dysfunction. The serine-threonine protein kinase mechanistic target of rapamycin (mTOR) regulates cellular metabolism, proliferation, and growth through two different protein complexes, mTORC1 and mTORC2. The PI3K-Akt-mTORC1 pathway's overactivity is well associated with heightened aggressiveness in thyroid cancer, but recent studies indicate the involvement of mTORC2 as well. METHODS: To elucidate mTORC1's role in thyrocytes, we developed a novel mouse model with mTORC1 gain of function in thyrocytes by deleting Tuberous Sclerosis Complex 2 (TSC2), an intracellular inhibitor of mTORC1...
April 25, 2024: Thyroid: Official Journal of the American Thyroid Association
https://read.qxmd.com/read/38658569/annexin-a2-combined-with-ttk-accelerates-esophageal-cancer-progression-via-the-akt-mtor-signaling-pathway
#35
JOURNAL ARTICLE
Ruiqi Liu, Yanwei Lu, Jing Li, Weiping Yao, Jiajun Wu, Xiaoyan Chen, Luanluan Huang, Ding Nan, Yitian Zhang, Weijun Chen, Ying Wang, Yongshi Jia, Jianming Tang, Xiaodong Liang, Haibo Zhang
Annexin A2 (ANXA2) is a widely reported oncogene. However, the mechanism of ANXA2 in esophageal cancer is not fully understood. In this study, we provided evidence that ANXA2 promotes the progression of esophageal squamous cell carcinoma (ESCC) through the downstream target threonine tyrosine kinase (TTK). These results are consistent with the up-regulation of ANXA2 and TTK in ESCC. In vitro experiments by knockdown and overexpression of ANXA2 revealed that ANXA2 promotes the progression of ESCC by enhancing cancer cell proliferation, migration, and invasion...
April 24, 2024: Cell Death & Disease
https://read.qxmd.com/read/38658095/repurposing-diacerein-to-suppress-colorectal-cancer-growth-by-inhibiting-the-dclk1-stat3-signaling-pathway
#36
JOURNAL ARTICLE
Qiaobei Ye, Yu Zhu, Meng Shi, Linxi Lv, Yuyan Gong, Luyao Zhang, Lehe Yang, Haiyang Zhao, Chengguang Zhao, Huanhai Xu
Double cortin-like kinase 1 (DCLK1) exhibits high expression levels across various cancers, notably in human colorectal cancer (CRC). Diacerein, a clinically approved interleukin (IL)-1β inhibitor for osteoarthritis treatment, was evaluated for its impact on CRC proliferation and migration, alongside its underlying mechanisms, through both in vitro and in vivo analyses. The study employed MTT assay, colony formation, wound healing, transwell assays, flow cytometry, and Hoechst 33342 staining to assess cell proliferation, migration, and apoptosis...
April 2024: Chinese Journal of Natural Medicines
https://read.qxmd.com/read/38656555/the-involvement-of-ripk4-in-tnf-%C3%AE-stimulated-il-6-and-il-8-production-by-melanoma-cells
#37
JOURNAL ARTICLE
Ewelina Madej, Anna Lisek, Anna A Brożyna, Agnieszka Cierniak, Norbert Wronski, Milena Deptula, Anna Wardowska, Agnieszka Wolnicka-Glubisz
PURPOSE: The receptor-interacting protein kinase (RIPK4) has an oncogenic function in melanoma, regulates NF-κB and Wnt/β-catenin pathways, and is sensitive to the BRAF inhibitors: vemurafenib and dabrafenib which lead to its decreased level. As its role in melanoma remains not fully understood, we examined the effects of its downregulation on the transcriptomic profile of melanoma. METHODS: Applying RNA-seq, we revealed global alterations in the transcriptome of WM266...
April 24, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38655290/aurka-promotes-renal-cell-carcinoma-progression-via-regulation-of-ccnb1-transcription
#38
JOURNAL ARTICLE
Jiling Wen, Xuechun Wang, Guosheng Yang, Junhua Zheng
AURKA is a member of the serine/threonine kinase family and its kinase activity is crucial for the progression of mitosis. Recent studies have highlighted the therapeutic significance of AURKA inhibition in multiple cancer types. However, the specific mechanisms by which AURKA contributes to the progression of renal cell carcinoma (RCC) have not been fully elucidated. In this study, AURKA expression level was identified in human RCC tissues by immunohistochemical (IHC) staining. The function of AURKA on cell malignant phenotypes was evaluated in vitro after AURKA inhibition...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38655145/comparative-safety-pharmacokinetics-and-off-target-assessment-of-1-1-bis-3-indolyl-1-p-chlorophenyl-methane-in-mouse-and-dog-implications-for-therapeutic-development
#39
JOURNAL ARTICLE
Savannah M Rocha, Daniel L Gustafson, Stephen Safe, Ronald B Tjalkens
The modified phytochemical derivative, 1,1-bis(3'-indolyl)-1-( p -chlorophenyl) methane (C-DIM12), has been identified as a potential therapeutic platform based on its capacity to improve disease outcomes in models of neurodegeneration and cancer. However, comprehensive safety studies investigating pathology and off-target binding have not been conducted. To address this, we administered C-DIM12 orogastrically to outbred male CD-1 mice for 7 days (50 mg/kg/day, 200 mg/kg/day, and 300 mg/kg/day) and investigated changes in hematology, clinical chemistry, and whole-body tissue pathology...
April 2024: Toxicology Research
https://read.qxmd.com/read/38650383/current-strategies-for-targeting-hpk1-in-cancer-and-the-barriers-to-preclinical-progress
#40
JOURNAL ARTICLE
Hui Chen, Xiangna Guan, Chi He, Tingting Lu, Xingyu Lin, Xuebin Liao
INTRODUCTION: Hematopoietic progenitor kinase 1 (HPK1), a 97-kDa serine/threonine Ste20-related protein kinase, functions as an intracellular negative regulator, primarily in hematopoietic lineage cells, where it regulates T cells, B cells, dendritic cells and other immune cells. Loss of HPK1 kinase activity results in exacerbated cytokine secretion, enhanced T cell signaling, improved viral clearance, and thus increased restraint of tumor growth. These findings highlight HPK1 as a promising target for immuno-oncology treatments, culminating in the advancement of candidate compounds targeting HPK1 to clinical trials by several biotech enterprises...
April 22, 2024: Expert Opinion on Therapeutic Targets
keyword
keyword
60105
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.